Rosalind Advisors, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001622627

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2024 · 39 positions · Total reported value $129.95M · Top-10 concentration 59.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 9 new · 11 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +4.7% · vs SPY +2.5% · Prev Value $269.06M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.8% · vs SPY -7.9% · Latest Value $244.66M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Rosalind Advisors, Inc. disclosed 39 equity positions with a combined reported value of $129.95M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.8% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were DCTH ($15.53M), MYO ($8.55M), MDWD ($7.97M). By sector, the heaviest allocations are Health Care 79.4%, Other 20.6%. Versus the prior quarter, allocation shifted toward Health Care (+9.7pp) and away from Other (-9.7pp).

Versus the prior quarter, Rosalind Advisors, Inc. opened 9 new positions, trimmed 11 and fully exited 3, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q2 2024 were ABEO ($7.42M), OCUL ($5.13M), CVSI ($1.30M).

Of the 3 positions fully exited versus the prior quarter, the largest were CARA ($1.41M), QQQ ($7.00K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • ABEO ABEONA THERAPEUTICS INC · $7.42M
  • OCUL OCULAR THERAPEUTIX INC · $5.13M
  • CVSI CASSAVA SCIENCES INC · $1.30M
  • ANVS ANNOVIS BIO INC · $839.17K
  • DERM JOURNEY MED CORP · $643.70K
  • TGTX TG THERAPEUTICS INC · $304.81K
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $194.46K
  • BTAI Bioxcel Therapeutics Inc · $50.78K

Fully Exited (vs previous quarter)

  • CARA CARA THERAPEUTICS INC · prev qtr: $1.41M
  • QQQ INVESCO QQQ TR · prev qtr: $7.00K · history

Insider Transactions (Form 4)

Latest Rosalind Advisors, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-13 J DELCATH SYSTEMS, INC. 27,502 — SEC filing
2026-10-13 Conversion DELCATH SYSTEMS, INC. 3,627 — SEC filing

All insider transactions →

Fund Profile

Rosalind Advisors, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 33 US equity positions with a combined value of $269.06M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Portfolio Structure

  • 33 positions · $269.06M reported value (Q2 2026)
  • Top 10 holdings = 74.1% of reported value
  • Largest position: DCTH (DELCATH SYS INC) at 15.4%
  • Average position size: $8.15M

Sector Tilt

  • Health Care 94.7%
  • Industrials 5.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 7 added, 12 reduced, 8 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 79.4%
Other 20.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.65M $15.53M 11.95%
11.95%
Add
2 2.66M $8.55M 6.58%
6.58%
Add
3 513.49K $7.97M 6.13%
6.13%
Add
4 7.55M $7.85M 6.04%
6.04%
Add
5 1.75M $7.42M 5.71%
5.71%
New
6 3.12M $7.02M 5.40%
5.40%
Add
7 2.71M $6.76M 5.21%
5.21%
Add
8 2.51M $6.27M 4.83%
4.83%
Add
9 19.30M $5.23M 4.03%
4.03%
Add
10 750.00K $5.13M 3.95%
3.95%
New
11 378.42K $5.00M 3.85%
3.85%
Hold
12 533.33K $4.47M 3.44%
3.44%
Hold
13 734.00K $4.43M 3.41%
3.41%
Hold
14 1.39M $4.15M 3.19%
3.19%
Add
15 337.99K $3.98M 3.06%
3.06%
Add
16 300.00K $3.90M 3.00%
3.00%
Hold
17 250.00K $3.62M 2.78%
2.78%
Hold
18 2.59M $3.37M 2.59%
2.59%
Hold
19 450.00K $3.32M 2.56%
2.56%
Add
20 2.70M $2.27M 1.75%
1.75%
Reduce
21 416.80K $1.79M 1.38%
1.38%
Hold
22 3.67K $1.30M 1.00%
1.00%
New
23 250.00K $1.07M 0.83%
0.83%
Add
24 255.56K $1.07M 0.83%
0.83%
Reduce
25 22.40K $1.04M 0.80%
0.80%
Reduce
26 607.80K $1.04M 0.80%
0.80%
Hold
27 200.00K $848.00K 0.65%
0.65%
Hold
28 24.15K $839.17K 0.65%
0.65%
New
29 1.57M $787.33K 0.61%
0.61%
Reduce
30 1.51M $780.91K 0.60%
0.60%
Hold
31 758.97K $675.48K 0.52%
0.52%
Hold
32 114.13K $643.70K 0.49%
0.49%
New
33 903.61K $485.51K 0.37%
0.37%
Hold
34 504.26K $452.83K 0.35%
0.35%
Hold
35 19.02K $304.81K 0.23%
0.23%
New
36 1.03M $286.32K 0.22%
0.22%
Reduce
37 10.12K $194.46K 0.15%
0.15%
New
38 39.67K $50.78K 0.04%
0.04%
New
39 28.15K $19.64K 0.01%
0.01%
Reduce

FAQ

What did Rosalind Advisors, Inc. buy in 2024-Q2?

In its 2024-Q2 13F filing, Rosalind Advisors, Inc. reported 39 equity positions worth $129.95M in aggregate; its largest disclosed positions were DCTH ($15.53M), MYO ($8.55M), MDWD ($7.97M).

How large is Rosalind Advisors, Inc.'s portfolio?

Rosalind Advisors, Inc. reported $129.95M of long equity holdings across 39 positions as of 2024-Q2. Top-10 holdings account for 59.8% of reported value.

What is Rosalind Advisors, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rosalind-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →